Recently, the George Institute for Global Health, together with Ningxia Medical University, Tufts University's Friedman School of Nutritional Sciences and Policy, and the Peking University Clinical Research Institute, jointly commenced the “Nuts and Chinese Adult Cardiovascular Disease Prevention Study” (NUTS), in order to provide solid and direct evidence for policy makings related to the consumption of nuts.
On November 10, 2019, an international academic symposium on "Healthcare, People and Media - Healthy China Initiative and Multiple Approaches to Health Communication" organized by the School of Journalism and Communication, Peking University, and The George Institute China was successfully held in Beijing. More than 100 people from the government, universities, media, hospitals, enterprises and public institutions participated in the forum, including 11 experts and scholars from the United States, Canada, Singapore, South Korea, and China, were invited as keynote speakers.
On 13 November 2019, The George Institute China officially moved into the Tayuan Diplomatic Office Building, Liangmahe of Chaoyang District in Beijing. Many of our staff were there to witness this exciting moment together.
On October 31, 2019, the first investigator meeting of Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial (INTERACT4) was held in the Shanghai East Hospital of Tongji University. Over 90 specialists including professor Craig Anderson, Executive Director of The George Institute China, and professor Li Gang, Director of the stroke center of Shanghai East Hospital of Tongji University attended the meeting.
On October 25, 2019, the "SAPPHIRE" project, which is aimed at strengthening China's rural public health service system to improve the management level of hypertension and diabetes, was officially launched in Beijing. More than 40 guests from the National Health Commission, National Center for Chronic and Noncommunicable Disease Control and Prevention of the Chinese Center for Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Sichuan Provincial Center for Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wenchuan Health Bureau, the Chinese Academy of Social Sciences, Peking University, Tsinghua University, University of Oxford, UNSW Sydney, Fuwai Hospital, Beijing Hospital, World Health Organization, The George Institute for Global Health, as well as enterprises from all walks of life and non-profit organizations witnessed this moment.
SYDNEY, SEPT 23 - The George Institute was today announced as one of 13 Australian organisations to receive an Athena SWAN Bronze Institution Award for its work in advancing gender equity and diversity as part of the Science in Australia Gender Equity (SAGE) initiative.
SYDNEY, SEPT 6 - A new meta-analysis published in Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
SYDNEY, SEPT 4 - Researchers from The George Institute for Global Health have been awarded almost $6m in Investigator Grants in the latest round of funding from the National Health and Medical Research Council (NHMRC).